Work

Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.6_suppl.396

Authors: Tracy L Rose, Michael Roger Harrison, Allison Mary Deal, Chelsea K. Osterman, Sundhar Ramalingam, Young E. Whang, Blaine Y Brower, Marc Bjurlin, Angela B. Smith, Matthew E. Nielsen, Hung-Jui Tan, Eric M. Wallen, Daniel J. George, Tian Zhang, Anthony Drier, William Y. Kim, Matthew I. Milowsky

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Duke University, Duke Cancer Institute

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4244288707

Cites:

Cited by: 8

Related to: 10